Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $222,365 (100.0% shares, 0.0% debt)

Holdings (12)

KMTS Kestra Med Technologies Ltd 17.6%

Value ($000) $39,106 Shares 1,645,893 Est. Cost $22.98 Unrealized -22.2%

BBNX Beta Bionics Inc. 17.2%

Value ($000) $38,153 Shares 1,920,125 Est. Cost $18.64 Unrealized -5.7%

BBOT BridgeBio Oncology Therapeutics Inc. 17.1%

Value ($000) $38,094 Shares 3,289,661 Est. Cost $11.58 Unrealized —

BCAX Bicara Therapeutics Inc. 15.7%

Value ($000) $34,811 Shares 2,204,650 Est. Cost $25.50 Unrealized -56.1%

NUVB Nuvation Bio 14.7%

Value ($000) $32,675 Shares 8,831,089 Est. Cost $11.18 Unrealized -75.6%

UPB Upstream Bio Inc. 11.5%

Value ($000) $25,512 Shares 1,356,293 Est. Cost $22.33 Unrealized -30.4%

IMA ImageneBio, Inc. 1.7%

Value ($000) $3,711 Shares 455,361 Est. Cost $13.25 Unrealized 0.0%

ENGN enGene Holdings Inc. 1.6%

Value ($000) $3,595 Shares 526,357 Est. Cost $10.40 Unrealized -56.1%

SANA Sana Biotechnology, Inc. 1.3%

Value ($000) $2,995 Shares 843,750 Est. Cost $32.56 Unrealized -88.9%

ALMS Alumis Inc. 1.2%

Value ($000) $2,606 Shares 653,223 Est. Cost $13.30 Unrealized -69.0%

REPL Replimune Group 0.5%

Value ($000) $1,042 Shares 248,672 Est. Cost $17.40 Unrealized -63.3%

ENGNW enGene Holdings Inc. 0.0%

Value ($000) $63 Shares 89,702 Est. Cost $0.85 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
KMTS	Kestra Med Technologies Ltd	1,645,893	$39,106	17.6%	$22.98	-22.2%	Common Stock	G52441105
BBNX	Beta Bionics Inc.	1,920,125	$38,153	17.2%	$18.64	-5.7%	Common Stock	08659B102
BBOT	BridgeBio Oncology Therapeutics Inc.	3,289,661	$38,094	17.1%	$11.58	—	Common Stock	107924102
BCAX	Bicara Therapeutics Inc.	2,204,650	$34,811	15.7%	$25.50	-56.1%	Common Stock	055477103
NUVB	Nuvation Bio	8,831,089	$32,675	14.7%	$11.18	-75.6%	Common Stock Class A	67080N101
UPB	Upstream Bio Inc.	1,356,293	$25,512	11.5%	$22.33	-30.4%	Common Stock	91678A107
IMA	ImageneBio, Inc.	455,361	$3,711	1.7%	$13.25	0.0%	Common Stock	45175G207
ENGN	enGene Holdings Inc.	526,357	$3,595	1.6%	$10.40	-56.1%	Common Stock	29286M105
SANA	Sana Biotechnology, Inc.	843,750	$2,995	1.3%	$32.56	-88.9%	Common Stock	799566104
ALMS	Alumis Inc.	653,223	$2,606	1.2%	$13.30	-69.0%	Common Stock	022307102
REPL	Replimune Group	248,672	$1,042	0.5%	$17.40	-63.3%	Common Stock	76029N106
ENGNW	enGene Holdings Inc.	89,702	$63	0.0%	$0.85	—	Warrant	29286M113